NCT04100824View on ClinicalTrials.gov

Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 11, 2020

Primary Completion Date

December 11, 2022

Study Completion Date

January 12, 2023

Conditions
Subarachnoid Hemorrhage
Interventions
PROCEDURE

stellate ganglion block by transcranial doppler

stellate ganglion block is a block of sympathetic ganglion

DRUG

Nimodipine

Nimodipine 60mg every 4h

Trial Locations (1)

1111111

ِAssiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04100824 - Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker | Biotech Hunter | Biotech Hunter